Naturally-acquired influenza-specific CD4 + T-cell proliferative responses are impaired in HIV-infected African adults

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Jambo, Kondwani C ^a   Sepako, Enoch ^a   Glennie, Sarah J ^b   Mzinza, David ^a   Williams, Neil A ^c   Gordon, Stephen B ^b   Heyderman, Robert S ^a  

^a UNIVERSITY OF MALAWI   (Malawi)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD40 LIGAND;

ADAPTIVE IMMUNITY; ADULT; ANTIGEN EXPRESSION; ARTICLE; ASYMPTOMATIC INFECTION; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLUENZA; LYMPHOCYTE PROLIFERATION; MALAWI; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; VIRUS IMMUNITY; VIRUS LOAD; CLINICAL TRIAL; HIV INFECTIONS; IMMUNOLOGY; INFLUENZA VIRUS A; INFLUENZA, HUMAN; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HIV INFECTIONS; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MALAWI; MALE; MIDDLE AGED;

EID: 84862019022     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038628     Document Type: Article

References (29)

1. CDC, (2009) Update: novel influenza A (H1N1) virus infections - worldwide, May 6, 2009. MMWR Morb Mortal Wkly Rep 58: 453-458.
2. UNAIDS, (2009) AIDS epidemic update: November 2009. UNAIDS.
3. Cooper CL, (2012) Pandemic H1N12009 influenza and HIV: a review of natural history, management and vaccine immunogenicity. Curr Opin Infect Dis 25: 26-35.
4. Sheth AN, Althoff KN, Brooks JT, (2011) Influenza susceptibility, severity, and shedding in HIV-infected adults: a review of the literature. Clin Infect Dis 52: 219-227.
5. Ormsby CE, de la Rosa-Zamboni D, Vazquez-Perez J, Ablanedo-Terrazas Y, Vega-Barrientos R, et al. (2011) Severe 2009 pandemic influenza A (H1N1) infection and increased mortality in patients with late and advanced HIV disease. Aids 25: 435-439.
6. WHO, (2008) The global burden of disease: 2004 update. Geneva WHO.
7. Mozdzanowska K, Furchner M, Zharikova D, Feng J, Gerhard W, (2005) Roles of CD4+ T-cell-independent and-dependent antibody responses in the control of influenza virus infection: evidence for noncognate CD4+ T-cell activities that enhance the therapeutic activity of antiviral antibodies. J Virol 79: 5943-5951.
8. Belz GT, Wodarz D, Diaz G, Nowak MA, Doherty PC, (2002) Compromised influenza virus-specific CD8(+)-T-cell memory in CD4(+)-T-cell-deficient mice. J Virol 76: 12388-12393.
9. Guthrie T, Hobbs CG, Davenport V, Horton RE, Heyderman RS, et al. (2004) Parenteral influenza vaccination influences mucosal and systemic T cell-mediated immunity in healthy adults. J Infect Dis 190: 1927-1935.
10. Jambo KC, Sepako E, Fullerton DG, Mzinza D, Glennie S, et al. (2011) Bronchoalveolar CD4+ T cell responses to respiratory antigens are impaired in HIV-infected adults. Thorax.
11. Glennie SJ, Sepako E, Mzinza D, Harawa V, Miles DJ, et al. (2011) Impaired CD4 T Cell Memory Response to Streptococcus pneumoniae Precedes CD4 T Cell Depletion in HIV-Infected Malawian Adults. PLoS One 6: e25610.
12. Subauste CS, Subauste A, Wessendarp M, (2007) Role of CD40-dependent down-regulation of CD154 in impaired induction of CD154 in CD4(+) T cells from HIV-1-infected patients. J Immunol 178: 1645-1653.
13. Subauste CS, Wessendarp M, Portilllo JA, Andrade RM, Hinds LM, et al. (2004) Pathogen-specific induction of CD154 is impaired in CD4+ T cells from human immunodeficiency virus-infected patients. J Infect Dis 189: 61-70.
14. Chattopadhyay PK, Yu J, Roederer M, (2006) Live-cell assay to detect antigen-specific CD4+ T-cell responses by CD154 expression. Nat Protoc 1: 1-6.
15. Lee N, Chan PK, Lui GC, Wong BC, Sin WW, et al. (2011) Complications and outcomes of pandemic 2009 Influenza A (H1N1) virus infection in hospitalized adults: how do they differ from those in seasonal influenza? J Infect Dis 203: 1739-1747.
16. Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, et al. (2010) Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 59: 1-62.
17. Schoub BD, (2010) Surveillance and management of influenza on the African continent. Expert Rev Respir Med 4: 167-169.
18. Roti M, Yang J, Berger D, Huston L, James EA, et al. (2008) Healthy human subjects have CD4+ T cells directed against H5N1 influenza virus. J Immunol 180: 1758-1768.
19. Richards KA, Topham D, Chaves FA, Sant AJ, (2010) Cutting edge: CD4 T cells generated from encounter with seasonal influenza viruses and vaccines have broad protein specificity and can directly recognize naturally generated epitopes derived from the live pandemic H1N1 virus. J Immunol 185: 4998-5002.
20. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A, (1999) Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712.
21. Geldmacher C, Ngwenyama N, Schuetz A, Petrovas C, Reither K, et al. (2010) Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4 T cells after HIV-1 infection. J Exp Med 207: 2869-2881.
22. Cagigi A, Nilsson A, Pensieroso S, Chiodi F, (2010) Dysfunctional B-cell responses during HIV-1 infection: implication for influenza vaccination and highly active antiretroviral therapy. Lancet Infect Dis 10: 499-503.
23. Stumptner-Cuvelette P, Morchoisne S, Dugast M, Le Gall S, Raposo G, et al. (2001) HIV-1 Nef impairs MHC class II antigen presentation and surface expression. Proc Natl Acad Sci U S A 98: 12144-12149.
24. McNamee LA, Harmsen AG, (2006) Both influenza-induced neutrophil dysfunction and neutrophil-independent mechanisms contribute to increased susceptibility to a secondary Streptococcus pneumoniae infection. Infect Immun 74: 6707-6721.
25. Montufar-Solis D, Garza T, Klein JR, (2007) T-cell activation in the intestinal mucosa. ImmunolRev 215: 189.
26. Florence E, Lundgren J, Dreezen C, Fisher M, Kirk O, et al. (2003) Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study. HIV Med 4: 255-262.
27. Crum-Cianflone NF, Eberly LE, Duplessis C, Maguire J, Ganesan A, et al. (2011) Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine in an immunocompromised population: a prospective study comparing HIV-infected adults with HIV-uninfected adults. Clin Infect Dis 52: 138-146.
28. Crum-Cianflone NF, Iverson E, Defang G, Blair PJ, Eberly LE, et al. (2011) Durability of antibody responses after receipt of the monovalent 2009 pandemic influenza A (H1N1) vaccine among HIV-infected and HIV-uninfected adults. Vaccine 29: 3183-3191.
29. Wilkinson TM, Li CK, Chui CS, Huang AK, Perkins M, et al. (2012) Preexisting influenza-specific CD4(+) T cells correlate with disease protection against influenza challenge in humans. Nat Med 18: 274-280.